FDA approves expanded use for Axsome Therapeutics' Auvelity, extending the medication's indication beyond its current treatment for depression.
The U.S. Food and Drug Administration has granted approval to Axsome Therapeutics for an expanded indication for its medication Auvelity, moving beyond its current use for depression.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near United States
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
Russia's consumer safety agency seeks info on mass tourist poisoning in Egypt's Xanadu Makadi Bay hotel
Russian health authority requests information on mass poisoning of Russian tourists in Egypt
U.S. asks Germany to help bring family of American Ebola patient from DRC
U.S. requests Germany's assistance to transport family members of an American Ebola patient from DRC.
American Ebola patient arrives in Berlin for treatment; WHO warns of further deaths.
An American Ebola patient has arrived in Berlin for treatment, sparking concern from the WHO over the outbreak.
European envoys seek Rubio clarification on U.S. troop drawdown in Europe, Financial Times reports
European envoys seek clarification from Marco Rubio over plans to reduce American troop levels in Europe, according to the Financial Times. The move has raised concerns among NATO allies about commitment to continental defense.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.